CLINICAL TRIALS PROFILE FOR DULOXETINE HYDROCHLORIDE

All Clinical Trials for duloxetine hydrochloride

Trial ID	Title	Status	Sponsor	Phase	Start Date	Summary
NCT00036309 ↗	Duloxetine Versus Placebo in the Prevention of Relapse of Major Depressive Disorder	Completed	Eli Lilly and Company	Phase 3	2002-05-01	The purpose of this study is to determine if duloxetine is effective when compared to placebo in preventing recurrence of major depressive disorder in patients who have responded to open-label duloxetine treatment.
NCT00036335 ↗	Subject Information and Consent Form F1J-US-HMCB Duloxetine Once-Daily Dosing Versus Placebo in Patients With Major Depression and Pain	Completed	Eli Lilly and Company	Phase 3	2002-03-01	The purposes of this study are to determine whether an investigational drug can help patients suffering from major depression with pain symptoms, and gather data on the safety of the investigational drug including any side effects that might be associated with it.
NCT00042562 ↗	Open-Label Treatment With Duloxetine Hydrochloride Once-Daily Dosing for Evaluation of Stabilization Dose in Patients With Major Depression	Completed	Eli Lilly and Company	Phase 3	2002-12-01	The purposes of this study are to determine: The safety of duloxetine and any side effects that might be associated with it. Whether duloxetine can help patients with major depression. The safety associated with switching from a medication you may be taking for depression to taking duloxetine. It is possible that information collected during this study will be analyzed by the sponsor in the future to evaluate duloxetine for other possible uses or for other medical or scientific purposes other than those currently proposed.
NCT00042575 ↗	Dose Escalation, Double-Blind Treatment With Duloxetine Hydrochloride Once Daily Dosing for Evaluation of Safety in Major Depression	Completed	Eli Lilly and Company	Phase 3	2002-06-01	The Purposes of this Study are to determine: The safety of duloxetine and any side effects that might be associated with it. Whether duloxetine can help patients with major depression. It is possible that information collected during this study will be analyzed by the sponsor in the future to evaluate duloxetine for other possible uses or for other medical or scientific purposes other than those currently proposed. Duloxetine might not have any good effects for you.
NCT00058968 ↗	A Study for the Treatment of Painful Diabetic Neuropathy	Completed	Eli Lilly and Company	Phase 3	2002-10-01	The purpose of the study is to determine if duloxetine can help patients with painful diabetic neuropathy.

Clinical Trial Conditions for duloxetine hydrochloride

Condition Name

Condition Name for duloxetine hydrochloride
Intervention	Trials
Major Depressive Disorder	56
Depression	32
Fibromyalgia	19
Pain	15

Condition MeSH

Condition MeSH for duloxetine hydrochloride
Intervention	Trials
Depression	121
Depressive Disorder	117
Depressive Disorder, Major	84
Disease	61

Clinical Trial Locations for duloxetine hydrochloride

Trials by Country

Trials by Country for duloxetine hydrochloride
Location	Trials
Canada	69
United Kingdom	34
Australia	33
France	32
Germany	28

Trials by US State

Trials by US State for duloxetine hydrochloride
Location	Trials
New York	62
California	57
Florida	55
Texas	51
Ohio	50

Clinical Trial Progress for duloxetine hydrochloride

Clinical Trial Phase

Clinical Trial Phase for duloxetine hydrochloride
Clinical Trial Phase	Trials
Phase 4	115
Phase 3	97
Phase 2/Phase 3	10

Clinical Trial Status

Clinical Trial Status for duloxetine hydrochloride
Clinical Trial Phase	Trials
Completed	233
Recruiting	40
Not yet recruiting	24

Clinical Trial Sponsors for duloxetine hydrochloride

Sponsor Name

Sponsor Name for duloxetine hydrochloride
Sponsor	Trials
Eli Lilly and Company	129
Boehringer Ingelheim	38
Shionogi	12

Sponsor Type

Sponsor Type for duloxetine hydrochloride
Sponsor	Trials
Other	295
Industry	237
NIH	26